title: Reply to: "need to consider full societal impact of hepatitis B virus-positive donors".
authors.affiliation: Icahn School of Medicine at Mount Sinai, Department of Medicine, New York, NY.
authors.forename: S
authors.initials: S
authors.lastname: Huprikar
authors.affiliation: Cincinnati Children's Hospital Medical Center, Department of Pediatrics, Cincinnati, OH.
authors.forename: L
authors.initials: L
authors.lastname: Danziger-Isakov
authors.affiliation: Oregon Health Sciences University, Department of Medicine, Portland, OR.
authors.forename: J
authors.initials: J
authors.lastname: Ahn
authors.affiliation: Massachusetts General Hospital, Department of Medicine, Boston, MA.
authors.forename: C N
authors.initials: CN
authors.lastname: Kotton
authors.affiliation: University of Toronto, Department of Medicine, Toronto, ON.
authors.forename: D
authors.initials: D
authors.lastname: Kumar
mesh_terms: D006509:Hepatitis B / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D016031:Liver Transplantation / Q000379:methods*; D014019:Tissue Donors
keywords: clinical research / practice; donors and donation: donor-derived infections; infection and infectious agents; infectious disease; viral: hepatitis B